Cross-Reactivity Conferred by Homologous and Heterologous Prime-Boost A/H5 Influenza Vaccination Strategies in Humans: A Literature Review.

Vaccines (Basel) · 2021 · PMC8708856 · PMID 34960210

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

For all immunological endpoints, a positive trend was observed between the value obtained against the homologous antigen to the vaccine and that obtained against heterologous antigens.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.